Phoenix7's Stock Sizzlers

[Phoenix7]

Oils may be starting to move? Check out CLR . Note How The Green Oscillator Line crossed over the Red Line around 3/21/16 That would have been the ideal time to enter!

Look Here at the Chart and Aroon Oscillator http://schrts.co/AfRbCR Looks as if money can still be made? 2nd CLR CHART: http://finviz.com/quote.ashx?t=CLR&ty=c&ta=1&p=d

Check Out Barron's Article http://blogs.barrons.com/stockstowat...rrons&ru=yahoo

MITK Interesting "NEW" Pick Chart: http://finviz.com/quote.ashx?t=MITK&ty=c&ta=1&p=d 2nd Chart: http://schrts.co/ksLJ07

[Phoenix7]

2 Stocks that may have more to go?

1. FDP http://schrts.co/sOiiqr 2nd Chart: http://finviz.com/quote.ashx?t=FDP&ty=c&ta=1&p=d

2. NSP http://schrts.co/e9dgoU 2nd Chart: http://finviz.com/quote.ashx?t=NSP&ty=c&ta=1&p=d

[Phoenix7]

Well no one knows what the stock markets will do in the coming week , and current conditions in the stock market seem precarious at best, and it is for that reason I am sticking with my Gold and Metal Stocks!

1. ABX http://schrts.co/kYtDQR 2nd Chart http://finviz.com/quote.ashx?t=ABX&ty=c&ta=1&p=d

2. AUY http://schrts.co/J3I1pC 2nd chart: http://finviz.com/quote.ashx?t=AUY&ty=c&ta=1&p=d

3. HL http://schrts.co/uGk86l 2nd Chart: http://finviz.com/quote.ashx?t=HL&ty=c&ta=1&p=d The location of its mines primarily in the U.S. and Canada means there is very little political risk, and it boasts considerable proven and probable reserves, with 175 million ounces of silver and 2 million ounces of gold.
Hecla is well positioned to take advantage of the rally in silver, with the company forecasting 2016 production of 39-40 million ounces, or almost 7% higher than 2015.
Furthermore, it ended 2015 with impressive cash costs of just $5.85 per ounce, well below those reported by the larger primary silver miners. With Hecla focusing on cutting expenses, including plans to reduce non-payroll costs by $25 million, its cash costs should continue to fall throughout 2016, allowing the company to generate a solid profit margin as silver appreciates.
Then there is its solid balance sheet, with $240 million in debt which is only 2.5 times its operating cash flow. Hecla is also highly liquid, with almost $270 million in cash and cash equivalents, as well as $142 million in working capital.
Accordingly, with Hecla boasting long-life reserves, mines in politically stable jurisdictions, low cash costs and solid production growth for 2016, I expect the stock to perform strongly over the course of the year.

4. FFMGF http://schrts.co/vpDOmB FFMGF was founded by Keith Neumeyer, who has previously built two billion dollar silver-focussed companies. First, Silver Standard Resources and then First Majestic , so he has had serial success as a mine developer. Keith is now focusing his considerable talents, experience, contacts (and fortune) to buying up promising but distressed projects for pennies on the dollar, and with his reputation has attracted other multi-millionaires like Rick Rule, Marin Katusa, and even billionaires like Eric Sprott as investors. Last I heard they had something like 60 project they were looking at for potential purchase, FFMGF could turn out to be a huge blockbuster!

FFMGF Additional Information: The company primarily explores for gold, silver, lead, zinc, and copper deposits. It holds interests in 19 mineral properties located in Mexico, the United States, and Canada. The company is headquartered in Vancouver, Canada

5. NKMTF http://schrts.co/C0iGBv Newmarket Gold has outperformed the GDX by 17%. Newmarket produced operating cash flow for the nine months ended 2015 finished at $65.9 million, a 34.8% increase year over year, while net income was $17.5 million or $.14 per share. Shares were trading at an EV/EBITDA of just 1.6, a Price/CFPS of 2.1, and a forward P/E of 4.77. So shares were pretty cheap compared to its peers.

Newmarket finished the 2015 year really strong, with year-end production of 222,671 gold ounces (exceeding guidance of 205,000 to 220,000 ounces) at $987 AISC; operating cash flow finished the year at $76.5 million, while the company's cash position increased to $36.5 million even after investing $12 million on exploration projects.

With a strong cash balance and virtually no debt, 205,000 to 220,000 ounces of production expected in 2016 at sub-$1,000 AISC, excellent exploration potential at its Fosterville Gold Mine, and a cheap valuation (3.31 EV/EBITDA and a 6.79 forward P/E, according to Yahoo Finance) Newmarket is in a great position to continue its out performance in 2016.


6. SLV http://schrts.co/J203nE 2nd Chart: http://finviz.com/quote.ashx?t=SLV&ty=c&ta=1&p=d

7. SVCMF http://www.barchart.com/chart.php?sy...&txtDate=#jump

Additional Information on SVCMF
SilverCrest is a Canadian precious metals exploration company headquartered in Vancouver, BC, that is focused on new discoveries, value-added acquisitions and targeting production in Mexico’s historic precious metal districts. The Company is led by a proven management team in all aspects of the precious metal mining sector, including experience and success in applying a responsible “phased approach” business model in taking projects from discovery, finance, on time and on budget construction, and production with subsequent increased value to shareholders. The Company was formed following the acquisition of SilverCrest Mines Inc. by First Majestic Silver Corp., which remains a shareholder in SilverCrest Metals Inc.

8. BRIZF http://schrts.co/tZL7MA This is another great project generator with strong and prominent shareholders including local Brazil bankers that have been compared to the ”Kennedy family” in the U.S. Management is top notch and they are deploying their capital judiciously to accumulate great assets for pennies on the dollar, the latest being uranium assets in the very prolific Athabasca Basin in Saskatchewan and gold assets in Manitoba. Once again the share price does not begin to reflect the VALUE of acquisitions since the company IPO’d and it has no problem raising money, much of it from existing strong, well-healed shareholders.
BRIZF Good Management http://brazilresources.com/investors/highlights/

BRIZF Currently $!.90 Per Share but .......Here's the Research Report from Cantor Fitzgerald which states a $2.90 Target Price. Worth the read.

http://bit.ly/1T9hUc0

NOT A METAL STOCK BUT IT TURNED UP IN MY MARKET TREND SIGNAL PROGRAM

AXTI http://finviz.com/quote.ashx?t=AXTI&ty=c&ta=1&p=d 2nd Chart: http://schrts.co/8POkm0 ZACKS RATES #1 "STRONG BUY!" http://finance.yahoo.com/news/earnin...125612973.html


NMKTF LOOKING GOOD! Read This: http://www.mining.com/web/newmarket-...the-beginning/ "LATEST" Good News http://finance.yahoo.com/news/newmar...103000393.html

THE ABOVE STOCKS STILL LOOK INTERESTING and Here are a few more stocks that could move higher during the coming week!

AVXS http://schrts.co/Cvt8vT 2nd Chart: A "Speculative" Medical stock http://finviz.com/quote.ashx?t=avxs&ty=c&ta=1&p=d

LRTNF http://www.barchart.com/chart.php?sy...&txtDate=#jump Another Gold Stock!

[Phoenix7]

2 Stocks with some short term $$$ possibilities:

1. RYI http://schrts.co/686Czt 2nd Chart : http://finviz.com/quote.ashx?t=RYI&ty=c&ta=1&p=d

2. TSE http://schrts.co/casm1W 2nd Chart: http://finviz.com/quote.ashx?t=tse&ty=c&ta=1&p=d

BONUS HIGH SPECULATION BIOTECH FOR THE "GAMBLERS" OUT THERE!

NTLA A recent IPO Here is the story: http://highexistence.com/links/view/...f-the-century/ Chart: http://schrts.co/jUkQqp 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

NTLA A "Short" Analysis! http://seekingalpha.com/article/3977...ng-opportunity

WATCH NEVR At the open ! http://finance.yahoo.com/news/minerv...121500474.html

[riverbabe]

BONUS HIGH SPECULATION BIOTECH FOR THE "GAMBLERS" OUT THERE!

NTLA A recent IPO Here is the story: http://highexistence.com/links/view/...f-the-century/ Chart: http://schrts.co/jUkQqp 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

NTLA A "Short" Analysis! http://seekingalpha.com/article/3977...ng-opportunity

CRISPR IS A GIANT LEAP FOR MANKIND! Seriously! Not ready to jump on the band wagon yet. Need to watch which companies emerge with it. And how they are managed. Long term trade I think.

[Phoenix7]

CRISPR IS A GIANT LEAP FOR MANKIND! Seriously! Not ready to jump on the band wagon yet. Need to watch which companies emerge with it. And how they are managed. Long term trade I think.

River I'm just watching also right now ........BUT NTLA does seem too good to be true?

[Phoenix7]

2 Stocks with some short term $$$ possibilities:

1. RYI http://schrts.co/686Czt 2nd Chart : http://finviz.com/quote.ashx?t=RYI&ty=c&ta=1&p=d

2. TSE http://schrts.co/casm1W 2nd Chart: http://finviz.com/quote.ashx?t=tse&ty=c&ta=1&p=d

BONUS HIGH SPECULATION BIOTECH FOR THE "GAMBLERS" OUT THERE!

NTLA A recent IPO Here is the story: http://highexistence.com/links/view/...f-the-century/ Chart: http://schrts.co/jUkQqp 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

NTLA A "Short" Analysis! http://seekingalpha.com/article/3977...ng-opportunity

WATCH NEVR At the open ! http://finance.yahoo.com/news/minerv...121500474.html

NERV Hot Damn Missed This One! http://schrts.co/CPMhTJ

[riverbabe]

NERV Hot Damn Missed This One! http://schrts.co/CPMhTJ

You sees? Sometimes it's "heads you win". Still crapshoot trading...

https://www.thestreet.com/story/13587382/1/biotech-stock-mailbag-sage-therapeutics-minerva.html?puc=yahoo&cm_ven=YAHOO

@adamfeuerstein do you have any thoughts on $nerv?
— pro stock (@researchprobio) May 26, 2016

"I confess to not knowing anything about Minerva Neurosciences (NERV) before Thursday when the stock soared 265% on the announced results from the MN-101 phase II study in schizophrenia. I don't know if these data are real or not, meaning if the efficacy of MN-101 can be confirmed when Minerva eventually runs larger studies.

I'm not helpful. Apologies. But take a look at the Minerva chart. It's a case study for why investors love biotech. You don't see stock charts like this in any other industry.

Back in March, I wrote a column about how to spot red flags in clinical trial data. Minerva's press release on Thursday trips some of those red flags. The phase II study was conducted mostly in Russia and Eastern Europe. Minerva disclosed the treatment effect sizes for MN-101 compared to placebo (the statistical measure) but the company did not provide baseline characteristics for patients or the actual numeric changes in the schizophrenia ratings scale over the course of the study.

Two patients discontinued from the study due to QTc prolongations (irregular heart rhythms). Minerva did not hold a conference call to discuss the study results so that investors and analysts could ask questions and get more details.

MN-101 could be the real thing. The Minerva study was randomized, double-blinded and used a placebo control. I'm just saying getting more detailed data from the MN-101 schizophrenia study is a good idea, particularly with the stock's extreme reaction. The CNS treatment landscape is littered with the corpses of drugs that looked awesome in small, phase II studies but then blew up in larger, phase III studies.

It's so much easier when you own these small-cap biotech stocks before they rocket higher."

[Phoenix7]

You sees? Sometimes it's "heads you win". Still crapshoot trading...

https://www.thestreet.com/story/13587382/1/biotech-stock-mailbag-sage-therapeutics-minerva.html?puc=yahoo&cm_ven=YAHOO

@adamfeuerstein do you have any thoughts on $nerv?
— pro stock (@researchprobio) May 26, 2016

"I confess to not knowing anything about Minerva Neurosciences (NERV) before Thursday when the stock soared 265% on the announced results from the MN-101 phase II study in schizophrenia. I don't know if these data are real or not, meaning if the efficacy of MN-101 can be confirmed when Minerva eventually runs larger studies.

I'm not helpful. Apologies. But take a look at the Minerva chart. It's a case study for why investors love biotech. You don't see stock charts like this in any other industry.

Back in March, I wrote a column about how to spot red flags in clinical trial data. Minerva's press release on Thursday trips some of those red flags. The phase II study was conducted mostly in Russia and Eastern Europe. Minerva disclosed the treatment effect sizes for MN-101 compared to placebo (the statistical measure) but the company did not provide baseline characteristics for patients or the actual numeric changes in the schizophrenia ratings scale over the course of the study.

Two patients discontinued from the study due to QTc prolongations (irregular heart rhythms). Minerva did not hold a conference call to discuss the study results so that investors and analysts could ask questions and get more details.

MN-101 could be the real thing. The Minerva study was randomized, double-blinded and used a placebo control. I'm just saying getting more detailed data from the MN-101 schizophrenia study is a good idea, particularly with the stock's extreme reaction. The CNS treatment landscape is littered with the corpses of drugs that looked awesome in small, phase II studies but then blew up in larger, phase III studies.

It's so much easier when you own these small-cap biotech stocks before they rocket higher."

River never had a position in NERV, but if I had , I would have sold after that huge up move! Today it appears to be falling.!

[Phoenix7]

For the dividend lovers here is a sweet long term pick for ya: CINF Day: 0.28% Wk: 1.46% Mo: 3.83% Yrly: 34.30% YTD: 16.00%
Strength Rank: 94 DIV%: 2.79 PE: 17.85 EPS: 0.89 ROE: 9.84%
Ann EPS Gro: 3.86% Last QTR EPS Gro: -19.09% Sales Gro QTR: 8.00%
Beta : 0.81 Market Cap : 11B Volume : 0.42M Exchange : NASDAQ
Book Value : 40.98 Information is from my Market Trend Signal Program!

CINF Chart: http://schrts.co/Lx35Cg 2nd Chart: http://finviz.com/quote.ashx?t=CINF&ty=c&ta=1&p=d

NTLA Just purchased a tiny position in NTLA http://schrts.co/vqqQyh 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

Please Note , "The QUIET PERIOD" for NTLA ends on 5/31/16 Read about it here! http://seekingalpha.com/article/3977...ng-opportunity Very IMPORTANT Point from the above report: "Data demonstrates that share prices often increase following the expiration of quiet periods; we are currently suggesting that investors buy shares of NTLA in advance of its IPO expiration date."

[Phoenix7]

Gold and metal stocks have been retreating lately, so below is a list of more diversified stocks. More information will follow. Tomorrow is Memorial Day, please remember to say a few prayers for all the departed service people and all those currently on duty. They ALL deserve our respect!

1. ALB http://schrts.co/wxOxSy 2nd Chart: http://finviz.com/quote.ashx?t=ALB&ty=c&ta=1&p=d

2. CLR http://schrts.co/Emppud 2nd Chart: http://finviz.com/quote.ashx?t=CLR&ty=c&ta=1&p=d

3. FNMA http://schrts.co/zmAAlO

4. HII http://schrts.co/FoOu4V 2nd Chart: http://finviz.com/quote.ashx?t=HII

5. MEET http://schrts.co/IYQfpX 2nd Chart: http://finviz.com/quote.ashx?t=MEET&ty=c&ta=1&p=d

6. NTLA http://schrts.co/1lk2cD Please Note , "The QUIET PERIOD" for NTLA ends on 5/31/16 Read about it here! http://seekingalpha.com/article/3977...ng-opportunity Very IMPORTANT Point from the above report: "Data demonstrates that share prices often increase following the expiration of quiet periods; we are currently suggesting that investors buy shares of NTLA in advance of its IPO expiration date." 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

7. RYI http://schrts.co/hyzYIx 2nd Chart http://finviz.com/quote.ashx?t=RYI

8. SCMP http://schrts.co/IuNWQL 2nd Chart http://finviz.com/quote.ashx?t=SCMP&ty=c&ta=1&p=d

[brad fio]

http://schrts.co/1lk2cD[/url] Please Note , "The QUIET PERIOD" for NTLA ends on 5/31/16 Read about it here! http://seekingalpha.com/article/3977...ng-opportunity Very IMPORTANT Point from the above report: "Data demonstrates that share prices often increase following the expiration of quiet periods; we are currently suggesting that investors buy shares of NTLA in advance of its IPO expiration date." 2nd Chart: http://finviz.com/quote.ashx?t=NTLA&ty=c&ta=1&p=d

There seems to be a bit of discrepancy on when the quiet period ends. The SA article mentions 06/01/16 but the link in the article to the NASDAQ site states 06/15/16.

Does anyone have another source for when the quiet period ends?

[Phoenix7]

There seems to be a bit of discrepancy on when the quiet period ends. The SA article mentions 06/01/16 but the link in the article to the NASDAQ site states 06/15/16.

Does anyone have another source for when the quiet period ends?

That 5/31/16 date for NTLA was not absolute but only an approximate date.

Future Target Prices look good!

MarketWatch News on NTLA

Intellia Therapeutics started at outperform with $39 stock price target at Credit Suisse

9:48 a.m. May 31, 2016

- Tomi Kilgore

Intellia Therapeutics started at market perform with $32 stock price target at Leerink Partners

9:38 a.m. May 31, 2016

- Tomi Kilgore

Intellia Therapeutics started at outperform with $38 stock price target at Wedbush Securities

7:47 a.m. May 31, 2016

[Phoenix7]

In this turbulent stock market some stocks always appear to fare well......... here are 3 as taken from the internet!

"Concentrate on the Unstoppable Trends because they’re backed by trillions of dollars.
Make sure you’ve got shares in companies like Becton, Dickinson and Co. (NYSE:BDX), American Water Works Co. (NYSE:AWK) and Altria Group Inc. (NYSE:MO), because they’re set to grow no matter what the Fed does next, no matter which way the election plays out, and most of all, no matter what happens in places like China and the Middle East"

[Phoenix7]

MEET http://schrts.co/IYQfpX I like MEET............ now for the rest of the story : http://seekingalpha.com/article/3978...85a4d&uprof=11 2nd chart Looking Good http://finviz.com/quote.ashx?t=MEET&ty=c&ta=1&p=d

ABX Looks like a buy right here http://schrts.co/7hg86I

As noted from the internet : " This year, ABX plans to mine 5 to 5.5 million ounces of gold at a cost of $760-$810 per ounce, Analysts believe overall ABX will report EPS of $0.55 this year and $0.70 next year.
In the long term, ABX should continue generating profits for "DECADES"! At the end of 2015, the company reported gold reserves of 91.9 million ounces."